Foreign-Trade Zone (FTZ) 93, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Durham, North Carolina

egister Online via the Government Publishing Office [ www.gpo.gov ] [FR Doc No: 2026-19698] ----------------------------------------------------------------------- DEPARTMENT OF COMMERCE Foreign-Trade Zones Board [B-122-2026] Foreign-Trade Zone (FTZ) 93, Notification of Proposed Production Activity; Eli Lilly and Company; (Drug Products); Durham, North Carolina Eli Lilly and Company submitted a notification of proposed production activity to the FTZ Board (the Board) for its facility in Durham, North Carolina within Subzone 93K. The notification conforming to the requirements of the Board's regulations (15 CFR 400.22) was received on September 17, 2026. Pursuant to 15 CFR 400.14(b), FTZ production activity would be limited to the specific foreign-status material(s)/component(s) and specific finished product(s) described in the submitted notification (summarized below) and subsequently authorized by the Board. The benefits that may stem from conducting production activity under FTZ procedures are explained in the background section of the Board's website--accessible via www.trade.gov/ftz . The proposed finished products include: Incretin-based therapy for blood glucose and weight management drug product in dosage/packaged form in filled syringes, vials, or delivery pens or semi-finished syringes; CGRP monoclonal antibody for migraine prevention drug product in dosage/packaged fo